{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T06:06:06Z","timestamp":1792994766022,"version":"4.5.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:p>\n                    The global plan to eradicate hepatitis C virus (HCV) led by the World Health Organization outlines the use of highly effective direct\u2010acting antiviral drugs (DAAs) to achieve elimination by 2030. Identifying individuals with active disease and investigation of the breadth of diversity of the virus in sub\u2010Saharan Africa (SSA) is essential as genotypes in this region (where very few clinical trials have been carried out) are distinct from those found in other parts of the world. We undertook a population\u2010based, nested case\u2010control study in Uganda and obtained additional samples from the Democratic Republic of Congo (DRC) to estimate the prevalence of HCV, assess strategies for disease detection using serological and molecular techniques, and characterize genetic diversity of the virus. Using next\u2010generation and Sanger sequencing, we aimed to identify strains circulating in East and Central Africa. A total of 7,751 Ugandan patients were initially screened for HCV, and 20 PCR\u2010positive samples were obtained for sequencing. Serological assays were found to vary significantly in specificity for HCV. HCV strains detected in Uganda included genotype (g) 4k, g4p, g4q, and g4s and a newly identified unassigned g7 HCV strain. Two additional unassigned g7 strains were identified in patients originating from DRC (one partial and one full open reading frame sequence). These g4 and g7 strains contain nonstructural (ns) protein 3 and 5A polymorphisms associated with resistance to DAAs in other genotypes. Clinical studies are therefore indicated to investigate treatment response in infected patients.\n                    <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>\n                    : Although HCV prevalence and genotypes have been well characterized in patients in well\u2010resourced countries, clinical trials are urgently required in SSA, where highly diverse g4 and g7 strains circulate.\n                  <\/jats:p>","DOI":"10.1002\/hep.30342","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T04:29:19Z","timestamp":1541132959000},"page":"1426-1441","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":42,"title":["Highly Diverse Hepatitis C Strains Detected in Sub\u2010Saharan Africa Have Unknown Susceptibility to Direct\u2010Acting Antiviral Treatments"],"prefix":"10.1097","volume":"69","author":[{"given":"Chris","family":"Davis","sequence":"first","affiliation":[{"name":"Medical Research Council \u2010 University of Glasgow Centre for Virus Research,Glasgow,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9525-7612","authenticated-orcid":false,"given":"George S.","family":"Mgomella","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2010 University of Cambridge,Cambridge,Cambridgeshire,United Kingdom"},{"name":"Wellcome Sanger Institute,Hinxton,Cambridgeshire,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"da Silva Filipe","sequence":"additional","affiliation":[{"name":"Medical Research Council \u2010 University of Glasgow Centre for Virus Research,Glasgow,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Frost","sequence":"additional","affiliation":[{"name":"University of Sherbrooke,Sherbrooke,Quebec,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Giroux","sequence":"additional","affiliation":[{"name":"University of Sherbrooke,Sherbrooke,Quebec,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Hughes","sequence":"additional","affiliation":[{"name":"Medical Research Council \u2010 University of Glasgow Centre for Virus Research,Glasgow,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hogan","sequence":"additional","affiliation":[{"name":"University of Sherbrooke,Sherbrooke,Quebec,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontiano","family":"Kaleebu","sequence":"additional","affiliation":[{"name":"Medical Research Council\/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine Uganda Research Unit,Entebbe,Uganda"},{"name":"Uganda Virus Research Institute,Entebbe,Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gershim","family":"Asiki","sequence":"additional","affiliation":[{"name":"Uganda Virus Research Institute,Entebbe,Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McLauchlan","sequence":"additional","affiliation":[{"name":"Medical Research Council \u2010 University of Glasgow Centre for Virus Research,Glasgow,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Niebel","sequence":"additional","affiliation":[{"name":"Medical Research Council \u2010 University of Glasgow Centre for Virus Research,Glasgow,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponsiano","family":"Ocama","sequence":"additional","affiliation":[{"name":"Department of Medicine,Makerere University College of Health Sciences,Kampala,Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pomila","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2010 University of Cambridge,Cambridge,Cambridgeshire,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver G.","family":"Pybus","sequence":"additional","affiliation":[{"name":"Department of Zoology,University of Oxford,Oxford,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"P\u00e9pin","sequence":"additional","affiliation":[{"name":"University of Sherbrooke,Sherbrooke,Quebec,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Simmonds","sequence":"additional","affiliation":[{"name":"Peter Medawar Building for Pathogen Research,University of Oxford,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Singer","sequence":"additional","affiliation":[{"name":"Medical Research Council \u2010 University of Glasgow Centre for Virus Research,Glasgow,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vattipally B.","family":"Sreenu","sequence":"additional","affiliation":[{"name":"Medical Research Council \u2010 University of Glasgow Centre for Virus Research,Glasgow,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Wekesa","sequence":"additional","affiliation":[{"name":"Uganda Virus Research Institute,Entebbe,Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2010 University of Cambridge,Cambridge,Cambridgeshire,United Kingdom"},{"name":"Wellcome Sanger Institute,Hinxton,Cambridgeshire,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald G.","family":"Murphy","sequence":"additional","affiliation":[{"name":"National Institute of Public Health of Quebec, Laboratory of Public Health of Quebec,Sainte\u2010Anne\u2010de\u2010Bellevue,Quebec,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manj","family":"Sandhu","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2010 University of Cambridge,Cambridge,Cambridgeshire,United Kingdom"},{"name":"Wellcome Sanger Institute,Hinxton,Cambridgeshire,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1482-0889","authenticated-orcid":false,"given":"Emma C.","family":"Thomson","sequence":"additional","affiliation":[{"name":"Medical Research Council \u2010 University of Glasgow Centre for Virus Research,Glasgow,United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"key":"hep30342-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of HCV genotypes","volume":"61","year":"2015","journal-title":"Hepatology"},{"key":"hep30342-bib-0004-20241017","first-page":"115ra1","article-title":"Novel adenovirus\u2010based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","year":"2012","journal-title":"Sci Transl Med"},{"key":"hep30342-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1093\/gbe\/evv202","article-title":"Evolutionary and phylogenetic analysis of the hepaciviruses and pegiviruses","volume":"7","year":"2015","journal-title":"Genome Biol Evol"},{"key":"hep30342-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of HCV into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"hep30342-bib-0007-20241017","first-page":"8194","article-title":"Identification of a novel HCV genotype from Punjab, India \u2010 expanding classification of HCV into 8 genotypes","volume":"110","year":"2018","journal-title":"J Infect Dis"},{"key":"hep30342-bib-0008-20241017","first-page":"318","article-title":"EASL clinical practice guidelines: management of HCV infection","volume":"59","year":"2014","journal-title":"J Hepatol"},{"key":"hep30342-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jhep.2017.06.035","article-title":"Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"hep30342-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","article-title":"The role of parenteral antischistosomal therapy in the spread of HCV in Egypt","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"hep30342-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.meegid.2013.01.021","article-title":"HCV infections in the DRC exhibit a cohort effect","volume":"19","year":"2013","journal-title":"Infect Genet Evol"},{"key":"hep30342-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S2468-1253(17)30257-1","article-title":"HCV and the absence of genomic data in low income countries: a barrier on the road to eradication?","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"Pt 6","key":"hep30342-bib-0013-20241017","first-page":"1341","article-title":"Complete nucleotide sequence of a type 4 HCV variant, the predominant genotype in the Middle East","volume":"78","year":"1997","journal-title":"J Gen Virol"},{"key":"hep30342-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/jmv.21240","article-title":"A set of reference sequences for the HCV genotypes 4d, 4f, and 4k covering the full ORF","volume":"80","year":"2008","journal-title":"J Med Virol"},{"issue":"Pt 6","key":"hep30342-bib-0015-20241017","first-page":"1173","article-title":"Full\u2010length sequences of 11 HCV genotype 2 isolates representing five subtypes and six unclassified lineages with unique geographical distributions and genetic variation patterns","volume":"93","year":"2012","journal-title":"J Gen Virol"},{"key":"hep30342-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/JCM.02831-14","article-title":"HCV genotype 7, a new genotype originating from Central Africa","volume":"53","year":"2015","journal-title":"J Clin Microbiol"},{"key":"hep30342-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"HCV guidance: AASLD\u2010IDSA recommendations for testing, managing, and treating adults infected with HCV","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"hep30342-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature13997","article-title":"The African genome variation project shapes medical genetics in Africa","volume":"517","year":"2015","journal-title":"Nature"},{"key":"hep30342-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/infdis\/jiw009","article-title":"Epidemic history and iatrogenic transmission of blood\u2010borne viruses in mid\u201020th century Kinshasa","volume":"214","year":"2016","journal-title":"J Infect Dis"},{"key":"hep30342-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/JCM.00330-16","article-title":"Comparison of next\u2010generation sequencing technologies for comprehensive assessment of full\u2010length HCV viral genomes","volume":"54","year":"2016","journal-title":"J Clin Microbiol"},{"key":"hep30342-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/JCM.02366-06","article-title":"Use of sequence analysis of the NS5B region for routine genotyping of HCV with reference to C\/E1 and 5' untranslated region sequences","volume":"45","year":"2007","journal-title":"J Clin Microbiol"},{"key":"hep30342-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/jmv.21817","article-title":"Poor performance of HCV antibody tests in hospital patients in Uganda","volume":"82","year":"2010","journal-title":"J Med Virol"},{"key":"hep30342-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2148-11-131","article-title":"The mode and tempo of HCV evolution within and among hosts","volume":"11","year":"2011","journal-title":"BMC Evol Biol"},{"key":"hep30342-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"947.e1","DOI":"10.1016\/j.cmi.2016.07.032","article-title":"First next\u2010generation sequencing full\u2010genome characterization of a HCV genotype 7 divergent subtype","volume":"22","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"hep30342-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"HCV resistance to direct\u2010acting antiviral drugs in interferon\u2010free regimens","volume":"151","year":"2016","journal-title":"Gastroenterology"},{"key":"hep30342-bib-0026-20241017","first-page":"1435","article-title":"Efficacy of NS5A inhibitors against HCV genotypes 1\u20137 and escape variants","volume":"54","year":"2017","journal-title":"Gastroenterology"},{"key":"hep30342-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jhep.2012.10.028","article-title":"Virologic response and characterisation of HCV genotype 2\u20136 in patients receiving TMC435 monotherapy (study TMC435\u2010C202)","volume":"58","year":"2013","journal-title":"J Hepatol"},{"key":"hep30342-bib-0028-20241017","first-page":"261ra153","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV\u2010specific T cell memory","volume":"6","year":"2014","journal-title":"Sci Transl Med"},{"key":"hep30342-bib-0029-20241017","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of HCV infection in 2015: a modelling study","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"hep30342-bib-0030-20241017","first-page":"695","article-title":"Diagnostic accuracy of tests to detect HCV antibody: a meta\u2010analysis and review of the literature","volume":"17","year":"2017","journal-title":"BMC Infect Dis"},{"key":"hep30342-bib-0031-20241017","first-page":"233","article-title":"Phylogeography and epidemic history of HCV genotype 4 in Africa","volume":"464\u2010465","year":"2014","journal-title":"Virology"},{"key":"hep30342-bib-0032-20241017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.virol.2015.03.038","article-title":"The full\u2010length genome sequences of nine HCV genotype 4 variants representing a new subtype 4s and eight unclassified lineages","volume":"482","year":"2015","journal-title":"Virology"},{"key":"hep30342-bib-0033-20241017","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/jvh.12795","article-title":"Resistance characterization of ledipasvir and velpatasvir in HCV genotype 4","volume":"25","year":"2018","journal-title":"J Viral Hepat"},{"key":"hep30342-bib-0034-20241017","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/hep.29671","article-title":"Glecaprevir\/pibrentasvir in patients with HCV genotype 1 or 4 and prior direct\u2010acting antiviral treatment failure","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"hep30342-bib-0035-20241017","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/hep.29601","article-title":"Benefit\u2010risk assessment for sofosbuvir\/velpatasvir\/voxilaprevir based on patient population and HCV genotype: FDA\u2019s evaluation","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"hep30342-bib-0036-20241017","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cgh.2017.11.023","article-title":"Patient\u2010reported outcomes following treatment of chronic HCV infection with sofosbuvir and velpatasvir, with or without voxilaprevir","volume":"16","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep30342-bib-0037-20241017","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jhep.2016.11.022","article-title":"Post\u2010treatment resistance analysis of HCV from phase II and III clinical trials of ledipasvir\/sofosbuvir","volume":"66","year":"2017","journal-title":"J. Hepatol"},{"key":"hep30342-bib-0038-20241017","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.28706","article-title":"Ledipasvir plus sofosbuvir for 12 weeks in patients with HCV genotype 4 infection","volume":"64","year":"2016","journal-title":"Hepatology"},{"key":"hep30342-bib-0039-20241017","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jhep.2017.07.019","article-title":"Reply to: \u201cResponse to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries\u201d","volume":"67","year":"2017","journal-title":"J. Hepatol"},{"key":"hep30342-bib-0040-20241017","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/JCM.00483-15","article-title":"Characterization of HCV recombination in Cameroon by use of nonspecific next\u2010generation sequencing","volume":"53","year":"2015","journal-title":"J Clin Microbiol"},{"key":"hep30342-bib-0041-20241017","doi-asserted-by":"crossref","first-page":"e1002696","DOI":"10.1371\/journal.ppat.1002696","article-title":"Analysis of functional differences between HCV NS5A of genotypes 1\u20137 in infectious cell culture systems","volume":"8","year":"2012","journal-title":"PLoS Pathog"},{"key":"hep30342-bib-0042-20241017","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28636","article-title":"Treatment of a patient with genotype 7 HCV infection with sofosbuvir and velpatasvir","volume":"64","year":"2016","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.30342","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.30342","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.30342","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201904000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T19:52:19Z","timestamp":1729194739000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201904000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.30342","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]},"assertion":[{"value":"2018-08-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}